Under the authorisation from the annual general meeting 2025, the board of Humana AB has resolved to repurchase no more than 1,000,000 own shares for the purpose of enabling the improvement of the company’s capital structure and to increase the flexibility for the board in connection with potential future corporate acquisitions.
Any repurchase will be made on Nasdaq Stockholm in accordance with the Nordic Main Market
Rulebook for Issuers of Shares and take place before the annual general meeting 2026. Own shares
may be repurchased to the extent the company’s holdings of own shares in total amounts to no more
than ten per cent of the total number of shares in the company.
The shares will be repurchased in cash and arranged by an investment firm or financial institution in
accordance with the applicable rules and regulations in the Nordic Main Market Rulebook for Issuers
of Shares.
For information on the implementation of the share repurchases, please see www.nasdaq.com and
www.humanagroup.com. Repurchase of shares will not be press released separately, unless
mandatory disclosure obligations apply.
The total number of shares in the company amounts to 51,826,058, of which the company at the time
of this press release holds 3,485,273 own shares.
For more information, please contact:
Christoffer Herou, CFO, +46 72 582 86 16, christoffer.herou@humana.se
Ewelina Pettersson, Head of IR, +46 73 074 79 12, ewelina.pettersson@humana.se